Skip to content
★ Sign in to follow
MT

Micro-Tech (Nanjing) Co.,Ltd Stock: price and insider trades · China

南微医学

CN·Mcap CN¥15BHealth Care

No insider purchase over the last 90 days. The latest, by 李宁, was filed 23 Aug 2022.

Micro-Tech (Nanjing) Co.,Ltd: what insiders have been doing

This page follows insider dealings at Micro-Tech (Nanjing) Co.,Ltd as filed with SSE / SZSE (CSRC), a company from the Health Care sector. No insider at Micro-Tech (Nanjing) Co.,Ltd has published a filing in the past twelve months. The most recent one dates from 1 December 2023.

Looking back to 2021, when coverage begins, insiders filed 10 purchases and 6 sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€1M
10 ops. · all time
Sell Volume
€10M
6 ops. · all time

Since the insiders bought

  • Filed 23 Aug 2022 · 1538 days ago · €23k
    -4.2%
    Entry CN¥75.95 · Close at T+365 CN¥72.78
  • Filed 22 Dec 2021 · 1782 days ago · €84k
    -46.7%
    Entry CN¥159.13 · Close at T+365 CN¥84.85
  • Filed 22 Dec 2021 · 1782 days ago · €84k
    -46.7%
    Entry CN¥159.13 · Close at T+365 CN¥84.85

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 7,578 of 26,914 companies
62.5
score / 100
Value
45
Quality
80
FCF yld2.9%
Earn yld3.8%
EV/EBITDA18.6x
ROE12%
Gross mgn64%
Net mgn18%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥79.88
Analyst consensus
3 analysts
·
CN¥90.51Target CN¥94.37(+18%)CN¥102.00
Income statement
RevenueCN¥3.2B
Gross profitCN¥2B64% margin
EBITDACN¥819.8M26% margin
Net incomeCN¥570.3M15.3% margin
Valuation
PER (trailing)29.2x
PER (forward)21.1x
P/Book3.6x
Beta0.34
Balance sheet & cash
Market capCN¥15B
Total debtCN¥241.2M
Free Cash FlowCN¥433M
Debt / Equity6%
Profitability & ownership
ROE11.9%
ROA7.8%
% insiders48.9%
% institutions17.6%
Last declaration on 1 December 2023
Declarations16 total
  • ▼
    董事,高级管理人员Executives
    22M CNY15SSE
    250,000 shares100.0% of flowA股XSHGSSE:173000007143192580
  • ▲
    核心技术人员Executives
    158,189 CNY4SSE
    2,052 shares21.7% of flowA股XSHGSSE:173000005804796800
    Canonical exit: 21 Nov 2022 (T+90)
  • ▲
    高级管理人员Executives
    603,450 CNY37SSE
    6,750 shares100.0% of flowA股XSHGSSE:173000005457336060
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    高级管理人员Executives
    603,450 CNY37SSE
    6,750 shares100.0% of flowA股XSHGSSE:173000005457336130
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    董事Executives
    1M CNY25SSE
    12,600 shares3.6% of flowA股XSHGSSE:173000005457335940
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    高级管理人员Executives
    750,960 CNY29SSE
    8,400 shares3.0% of flowA股XSHGSSE:173000005457335900
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    高级管理人员Executives
    1M CNY37SSE
    12,600 shares100.0% of flowA股XSHGSSE:173000005457336100
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    核心技术人员Executives
    321,840 CNY28SSE
    3,600 shares100.0% of flowA股XSHGSSE:173000005457336000
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    核心技术人员Executives
    603,450 CNY28SSE
    6,750 shares78.3% of flowA股XSHGSSE:173000005457336160
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    高级管理人员Executives
    603,450 CNY37SSE
    6,750 shares100.0% of flowA股XSHGSSE:173000005457335970
    Canonical exit: 22 Mar 2022 (T+90)
  • ▲
    董事Executives
    2M CNY33SSE
    21,000 shares100.0% of flowA股XSHGSSE:173000005457336030
    Canonical exit: 22 Mar 2022 (T+90)
  • ▼
    高级管理人员Executives
    11M CNY27SSE
    40,000 shares41.2% of flowA股XSHGSSE:173000004436548100
  • ▼
    董事,高级管理人员Executives
    2M CNY20SSE
    8,108 shares6.2% of flowA股XSHGSSE:173000004441629900
  • ▼
    董事,高级管理人员Executives
    31M CNY27SSE
    118,946 shares90.2% of flowA股XSHGSSE:173000004441633570
  • ▼
    高级管理人员Executives
    14M CNY16SSE
    51,500 shares50.1% of flowA股XSHGSSE:173000004441223600
  • ▼
    高级管理人员Executives
    2M CNY12SSE
    6,000 shares5.7% of flowA股XSHGSSE:173000004432459700

16 of 16 declarations

About Micro-Tech (Nanjing) Co.,Ltd

南微医学 is a company in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative medical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations